119 related articles for article (PubMed ID: 22182931)
1. Association between the rs2910164 polymorphism in pre-mir-146a and oral carcinoma progression.
Hung PS; Chang KW; Kao SY; Chu TH; Liu CJ; Lin SC
Oral Oncol; 2012 May; 48(5):404-8. PubMed ID: 22182931
[TBL] [Abstract][Full Text] [Related]
2. miR-146a enhances the oncogenicity of oral carcinoma by concomitant targeting of the IRAK1, TRAF6 and NUMB genes.
Hung PS; Liu CJ; Chou CS; Kao SY; Yang CC; Chang KW; Chiu TH; Lin SC
PLoS One; 2013; 8(11):e79926. PubMed ID: 24302991
[TBL] [Abstract][Full Text] [Related]
3. Genetic variants in microRNA-146a (C>G) and microRNA-1269b (G>C) are associated with the decreased risk of oral premalignant lesions, oral cancer, and pharyngeal cancer.
Chen HC; Tseng YK; Chi CC; Chen YH; Yang CM; Huang SJ; Lee YC; Liou HH; Tsai KW; Ger LP
Arch Oral Biol; 2016 Dec; 72():21-32. PubMed ID: 27525378
[TBL] [Abstract][Full Text] [Related]
4. miR-24 up-regulation in oral carcinoma: positive association from clinical and in vitro analysis.
Lin SC; Liu CJ; Lin JA; Chiang WF; Hung PS; Chang KW
Oral Oncol; 2010 Mar; 46(3):204-8. PubMed ID: 20138800
[TBL] [Abstract][Full Text] [Related]
5. Association of single nucleotide polymorphism miRNA-146a (rs2910164) with increased predisposition to oral squamous cell carcinoma in central India population.
Tiwari S; Pandey R; Kumar V; Das S; Gupta V; Vishwakarma S; Nema R; Sindhuja T; Hashmi S; Kumar A
Cancer Biomark; 2023; 38(2):203-214. PubMed ID: 37545224
[TBL] [Abstract][Full Text] [Related]
6. Functional diversity of miR-146a-5p and TRAF6 in normal and oral cancer cells.
Min SK; Jung SY; Kang HK; Park SA; Lee JH; Kim MJ; Min BM
Int J Oncol; 2017 Nov; 51(5):1541-1552. PubMed ID: 29048658
[TBL] [Abstract][Full Text] [Related]
7. No association of pre-microRNA-146a rs2910164 polymorphism and risk of hepatocellular carcinoma development in Turkish population: a case-control study.
Akkız H; Bayram S; Bekar A; Akgöllü E; Usküdar O; Sandıkçı M
Gene; 2011 Oct; 486(1-2):104-9. PubMed ID: 21807077
[TBL] [Abstract][Full Text] [Related]
8. MiR-146a-5p inhibits proliferation and promotes apoptosis of oral squamous cell carcinoma cells by regulating NF-κB signaling pathway.
Zhu FY; Gan CW; Wang MX; Sun BC; Li FJ; Qiu YH; Wang K
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3717-3723. PubMed ID: 32329848
[TBL] [Abstract][Full Text] [Related]
9. miR-196a overexpression and miR-196a2 gene polymorphism are prognostic predictors of oral carcinomas.
Liu CJ; Tsai MM; Tu HF; Lui MT; Cheng HW; Lin SC
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S406-14. PubMed ID: 23138850
[TBL] [Abstract][Full Text] [Related]
10. Association of expression aberrances and genetic polymorphisms of lysyl oxidase with areca-associated oral tumorigenesis.
Shieh TM; Lin SC; Liu CJ; Chang SS; Ku TH; Chang KW
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4378-85. PubMed ID: 17671119
[TBL] [Abstract][Full Text] [Related]
11. Passenger strand miRNA miR-31* regulates the phenotypes of oral cancer cells by targeting RhoA.
Chang KW; Kao SY; Wu YH; Tsai MM; Tu HF; Liu CJ; Lui MT; Lin SC
Oral Oncol; 2013 Jan; 49(1):27-33. PubMed ID: 22854067
[TBL] [Abstract][Full Text] [Related]
12. A Noninvasive Test for MicroRNA Expression in Oral Squamous Cell Carcinoma.
Gissi DB; Morandi L; Gabusi A; Tarsitano A; Marchetti C; Cura F; Palmieri A; Montebugnoli L; Asioli S; Foschini MP; Scapoli L
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29914173
[TBL] [Abstract][Full Text] [Related]
13. The rs2910164 variant is associated with reduced miR-146a expression but not cytokine levels in patients with type 2 diabetes.
Alipoor B; Ghaedi H; Meshkani R; Omrani MD; Sharifi Z; Golmohammadi T
J Endocrinol Invest; 2018 May; 41(5):557-566. PubMed ID: 29058209
[TBL] [Abstract][Full Text] [Related]
14. The association between miR-499a polymorphism and oral squamous cell carcinoma progression.
Hou YY; Lee JH; Chen HC; Yang CM; Huang SJ; Liou HH; Chi CC; Tsai KW; Ger LP
Oral Dis; 2015 Mar; 21(2):195-206. PubMed ID: 24690080
[TBL] [Abstract][Full Text] [Related]
15. Increase of microRNA miR-31 level in plasma could be a potential marker of oral cancer.
Liu CJ; Kao SY; Tu HF; Tsai MM; Chang KW; Lin SC
Oral Dis; 2010 May; 16(4):360-4. PubMed ID: 20233326
[TBL] [Abstract][Full Text] [Related]
16. Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer.
Kozaki K; Imoto I; Mogi S; Omura K; Inazawa J
Cancer Res; 2008 Apr; 68(7):2094-105. PubMed ID: 18381414
[TBL] [Abstract][Full Text] [Related]
17. Role of the MIR146A polymorphism in the origin and progression of oral squamous cell carcinoma.
Palmieri A; Carinci F; Martinelli M; Pezzetti F; Girardi A; Cura F; Rubini C; Scapoli L
Eur J Oral Sci; 2014 Jun; 122(3):198-201. PubMed ID: 24612133
[TBL] [Abstract][Full Text] [Related]
18. Protease-activated Receptor-2 (PAR-2)-mediated Nf-κB Activation Suppresses Inflammation-associated Tumor Suppressor MicroRNAs in Oral Squamous Cell Carcinoma.
Johnson JJ; Miller DL; Jiang R; Liu Y; Shi Z; Tarwater L; Williams R; Balsara R; Sauter ER; Stack MS
J Biol Chem; 2016 Mar; 291(13):6936-45. PubMed ID: 26839311
[TBL] [Abstract][Full Text] [Related]
19. The variant of pri-mir-26a-1 polymorphism is associated with decreased risk of betel quid-related oral premalignant lesions and oral squamous cell carcinoma.
Yang CM; Chen CC; Tseng YK; Huang SJ; Liou HH; Lee YC; Lee JH; Wang JS; Chen HC; Chi CC; Kang BH; Lin YC; Tsai KW; Ger LP
Oral Surg Oral Med Oral Pathol Oral Radiol; 2017 Oct; 124(4):378-389.e1. PubMed ID: 28743663
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of microRNA 99a in oral squamous cell carcinomas contributes to the growth and survival of oral cancer cells.
Yan B; Fu Q; Lai L; Tao X; Fei Y; Shen J; Chen Z; Wang Q
Mol Med Rep; 2012 Sep; 6(3):675-81. PubMed ID: 22751686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
